INTRODUCTION Because of their excellent biocompatibility, poly(ethylene glycol) (PEG) and its derivatives have been widely used in biomedical applications, especially in drug PEGylation, biomaterial surface modification, and hydrogelbased implants and tissue scaffolds. [1][2][3][4][5][6][7][8] To be incorporated into a hydrogel structure, the hydroxyl end group of PEG is usually and conveniently reacted with acryloyl chloride to form an acrylate structure (PEG-A, Scheme 1), 9-11 which subsequently undergoes either a free radical polymerization or the Michael-type addition reaction with thiol-containing molecules. 11-14 Consequently, the formed hydrogel structure contains ester linkages at the crosslink points, and their hydrolysis (half time of the ester bonds in the water-rich environment is on the order of days at pH 7.4 and 37 C) will result in disintegration of the gel, 15-17 which is an advantage for applications requiring gel degradation but a disadvantage for longer term applications such as vitreous, cartilage, and nucleus pulposus replacement.